Moberg Pharma AB (publ) (STO:MOB)

Sweden · Delayed Price · Currency is SEK

10.08

+0.05 (0.50%)

Mar 25, 2026, 4:55 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Commercialization and Development of Medical Products	13.54M	9.81M		207.00K		33.66M	50.49M
Commercialization and Development of Medical Products Growth	37.99%	-		-		-33.33%	62.30%
Total	13.54M	9.81M		207.00K		33.66M	50.49M
Total Growth	37.99%	-		-		-33.33%	62.30%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Europe	9.81M		-		-	-
Rest of The World	-		207.00K		33.66M	-
Total	9.81M		207.00K		33.66M	-

Source: S&P Global Market Intelligence.